Department of Cardiology, Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Cardiology, Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
J Am Coll Cardiol. 2013 Oct 29;62(18):1660-1670. doi: 10.1016/j.jacc.2013.06.046. Epub 2013 Jul 31.
This study sought to examine the relationships between right ventricular (RV) function, body composition, and prognosis in patients with advanced heart failure (HF).
Previous studies investigating HF-related cachexia have not examined the impact of RV function on body composition. We hypothesized that RV dysfunction is linked to weight loss, abnormal body composition, and worsened prognosis in advanced HF.
Subjects with advanced HF (n = 408) underwent prospective assessment of body composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blood testing. Subjects were followed up for adverse events (defined as death, transplantation, or circulatory assist device).
Subjects with RV dysfunction (51%) had lower body mass index, lower fat mass index, and were more likely to display cachexia (19%). The extent of RV dysfunction correlated with greater antecedent weight loss and a lower fat/lean body mass ratio. Over a median follow-up of 541 days, there were 150 events (37%). Risk of event was greater in subjects with RV dysfunction (hazard ratio: 3.09 [95% confidence interval (CI): 2.18 to 4.45]) and cachexia (hazard ratio: 2.90 [95% CI: 2.00 to 4.12]) in univariate and multivariate analyses. Increased body mass index was associated with a lower event rate (HR per kg/m(2): 0.92 [95% CI: 0.88 to 0.96]), and this protection was mediated by a higher fat mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]).
RV dysfunction and cardiac cachexia often coexist, have additive adverse impact, and might be mechanistically interrelated. Wasting of fat but not of lean mass was predictive of adverse outcome, suggesting that fat loss is either a surrogate of enhanced catabolism or adipose tissue is cardioprotective in the context of HF.
本研究旨在探讨右心室(RV)功能、身体成分与晚期心力衰竭(HF)患者预后之间的关系。
既往研究 HF 相关性恶病质时并未探讨 RV 功能对身体成分的影响。我们假设 RV 功能障碍与体重减轻、身体成分异常及晚期 HF 预后恶化有关。
前瞻性评估 408 例晚期 HF 患者的身体成分(皮褶厚度、双能 X 射线吸收法)、综合超声心动图和血液检查。对患者进行随访以观察不良事件(定义为死亡、移植或循环辅助装置)。
RV 功能障碍(51%)患者的体重指数、脂肪质量指数较低,更有可能发生恶病质(19%)。RV 功能障碍的严重程度与更大程度的前驱体重减轻和更低的脂肪/瘦体重比值相关。中位随访 541 天后,共发生 150 例事件(37%)。在单变量和多变量分析中,RV 功能障碍(风险比:3.09[95%置信区间:2.18 至 4.45])和恶病质(风险比:2.90[95%置信区间:2.00 至 4.12])患者的风险更高。体重指数增加与更低的事件发生率相关(每公斤体重的 HR:0.92[95%置信区间:0.88 至 0.96]),而这一保护作用是通过更高的脂肪量介导的(0.91[95%置信区间:0.87 至 0.96]),而不是通过无脂肪质量指数(0.97[95%置信区间:0.92 至 1.03])。
RV 功能障碍和心脏恶病质常同时存在,具有累加的不良影响,并且可能在机制上相互关联。脂肪丢失而非瘦体重丢失与不良预后相关,这表明在 HF 背景下,脂肪丢失可能是增强分解代谢的替代指标,或者脂肪组织对心脏具有保护作用。